Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126769891 | 12676989 | 1 | I | 20160808 | 20160823 | 20160823 | EXP | TN-HERITAGE PHARMACEUTICALS-2016HTG00203 | HERITAGE | M^RAD A, ESSAFI F, FOUDHAILI N, ET AL.. ACUTE NIFEDIPINE POISONING: CLINICAL AND PROGNOSIS ASPECTS. ANN INTENSIVE CARE. 2016;6(SUPPL. 1):P148 | 0.00 | Y | 0.00000 | 20160823 | MD | TN | TN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126769891 | 12676989 | 1 | PS | NIFEDIPINE. | NIFEDIPINE | 1 | Oral | 202644 | |||||||||||
| 126769891 | 12676989 | 2 | SS | THEOPHYLLINE | THEOPHYLLINE ANHYDROUS | 1 | Oral | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126769891 | 12676989 | HO |
| 126769891 | 12676989 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126769891 | 12676989 | Overdose | |
| 126769891 | 12676989 | Shock | |
| 126769891 | 12676989 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |